34Th Street Cancer Center Inc

Nonprofit profile at a glance

EIN
300262470
IRS 990-EZ coverage
2014–2024
Forms available
Form 990 2013, Form 990-EZ 2024
Location
New York, NY, USA
Phone
2122633474
Rating confidence
Limited
Sector
Hospitals and Related Primary Medical Care Facilities

Reported finances

Revenue
$0
Expenses
$0
Assets
$0
Liabilities
$0

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

5 people listed

Executive titles in this filing

  • ROBERT I GROSSMAN MD (PRESIDENT)
  • ANDREW W BROTMAN MD (VICE PRESIDENT)

People named in this filing

  • ROBERT I GROSSMAN MD (PRESIDENT)
  • ANDREW W BROTMAN MD (VICE PRESIDENT)
  • JOSEPH J LHOTA (TREASURER)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The purposes of the organization are: to promote and support the diagnosis and treatment of cancer and basic and applied biomedical and other scientific research and related educational services in the field of oncology; to own and lease real estate in order to enhance and to provide facilities for the conduct of such diagnosis, treatment, biomedical and other scientific research, education and other hospital related support functions; to promote and support education in the field of oncology and such research and to own, lease and operate facilities that provide educational services, all primarily in connection with nyu langone hospitals ("hospitals"), and to achieve its purposes by conducting and supporting activities for the benefit of, performing the functions of, or carrying out the purposes of hospitals center. The cancer center is a 13-story, 115,000 square foot facility that consolidates and expands the previous outpatient services of hospitals.

What it reported doing in 2024

Manage property associated with cancer center operations. On february 6, 2007 all assets and operations were acquired by and transferred to nyu langone hospitals.

Operating model

Revenue model
No positive adjusted resources. The filing reports no positive adjusted operating resources.
Distribution model
No current program activity. The filing reports no program spending for the current year.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: NotEnoughData
  • Transparency & Controls: 55
  • Sustainability: NotEnoughData
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: Limited

Transparency & Controls

  • Consistency checks: 66.7%; rating input score 67; 1st percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: Limited
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: Limited

Growth

  • Program expense growth: Limited
  • Revenue growth: -31.7% per year; rating input score 0; 10th percentile among comparable filings
  • Asset growth: -26.1% per year; rating input score 0; 8th percentile among comparable filings

Details

  • Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 5 people listed
  • Consistency: 6 of 7 current checks pass · 1 finding to review
  • Schedules: 1 filed schedules
  • Filing history: 8 filing years from 2014 to 2024
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Related organizations: 20 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Transparency & Controls: Series filing activity did not reconcile in the filed values.
  • High — Growth: Revenue growth scored 0/100.
  • High — Growth: Asset growth scored 0/100.